(Q30374442)

18 August 2017

Antiviral prophylaxis during pandemic influenza may increase drug resistance. (English)

1 reference

18 August 2017

0 references

2

Markus Schwehm

1 reference

18 August 2017

3

Hans-Peter Duerr

1 reference

18 August 2017

Beatriz Vidondo

7

0 references

author name string

Martin Eichner

1

1 reference

18 August 2017

Mark Witschi

4

1 reference

18 August 2017

Daniel Koch

5

1 reference

18 August 2017

Stefan O Brockmann

6

1 reference

18 August 2017

20 January 2009

1 reference

18 August 2017

BMC Infectious Diseases

1 reference

18 August 2017

9

1 reference

18 August 2017

4

1 reference

Creative Commons Attribution 2.0 Generic

18 August 2017

start time

20 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-9-4

0 references

cites work

Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Population-wide emergence of antiviral resistance during pandemic influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Influenza virus susceptibility and resistance to oseltamivir.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

The influenza pandemic preparedness planning tool InfluSim

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Comparative estimation of the reproduction number for pandemic influenza from daily case notification data.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Antiviral resistance and the control of pandemic influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

The role of compensatory mutations in the emergence of drug resistance

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Emergence of drug-resistant influenza virus: population dynamical considerations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Strategies for containing an emerging influenza pandemic in Southeast Asia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Containing pandemic influenza at the source.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Containing pandemic influenza with antiviral agents.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Predicting and preventing the emergence of antiviral drug resistance in HSV-2.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Emergence of drug resistance during an influenza epidemic: insights from a mathematical model

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Emergence of drug resistance: implications for antiviral control of pandemic influenza.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2334-9-4

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

Management of drug resistance in the population: influenza as a case study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2654456

26 November 2018

Identifiers

DOI

10.1186/1471-2334-9-4

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

19154598

1 reference